STOCK TITAN

Xcelerate Completes Audit of Consolidated Annual Financial Statements

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Xcelerate, Inc. (OTC Pink Sheets: XCRT) announced the completion of its Consolidated Annual Financial Statements audit for FY 2019 and FY 2020, conducted by BF Borgers CPA PC, a PCAOB registered firm. This achievement is a significant step towards the company's objective to uplist to OTCQB or QX, eventually aiming for a national exchange. The company focuses on acquiring and commercializing medical innovations, combining them with early-stage med tech enterprises.

Positive
  • Completion of audit for FY 2019 and FY 2020 enhances credibility.
  • Progress towards uplisting to OTCQB or QX could increase visibility and attract investors.
Negative
  • None.

MAULDIN, S.C., July 29, 2021 /PRNewswire/ -- Xcelerate, Inc. (OTC Pink Sheets: "XCRT") today announced the completion of the audit of its Consolidated Annual Financial Statements for the fiscal years ending December 31, 2019, and December 31,2020.  

As previously announced, an independent auditor and PCOAB registered accounting firm, BF Borgers CPA PC, completed the audit of the Company's financial statements within the guidelines of Generally Accepted Accounting Principles (GAAP).

Xcelerate CEO Michael O'Shea commented that, "the completion of the audits is a major step in our previously announced plan to complete an uplisting to OTCQB or QX, with the ultimate goal of uplisting to a national exchange."

ABOUT THE COMPANY
Xcelerate has assembled an internationally recognized team of translational clinicians and engineers to identify, acquire and commercialize medical IP, engineering advancements and intellectual property that does not have immediately obvious applications to medical technology and clinical care. Xcelerate acquires innovation at the engineering / patent level, marries it with appropriate early-stage operational med tech companies and applies it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella.

SAFE HARBOR
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.

For more information about Xcelerate, Inc. please visit company's website; www.xcelerate.global.

Media contact: Justin Baronoff 561-750-9800; justin@transmediagroup.com.

Cision View original content:https://www.prnewswire.com/news-releases/xcelerate-completes-audit-of-consolidated-annual-financial-statements-301344439.html

SOURCE Xcelerate, Inc.

FAQ

What did Xcelerate announce on July 29, 2021?

Xcelerate announced the completion of its Consolidated Annual Financial Statements audit for the fiscal years ending December 31, 2019, and December 31, 2020.

Who conducted the audit for Xcelerate?

The audit was conducted by BF Borgers CPA PC, a PCAOB registered accounting firm.

What is the significance of the completed audit for Xcelerate?

The completed audit is a crucial step in Xcelerate's plan to uplist to OTCQB or QX, aiming for a national exchange.

What is Xcelerate's business focus?

Xcelerate focuses on acquiring and commercializing medical innovations and engineering advancements within the med tech sector.

What is the stock symbol for Xcelerate?

The stock symbol for Xcelerate is XCRT.

XCELERATE INC

OTC:XCRT

XCRT Rankings

XCRT Latest News

XCRT Stock Data

10.73M
254.49M
41.61%
Medical Care Facilities
Healthcare
Link
United States of America
Mauldin